ASIA'S #1 BIOPROCESSING EVENT - CELEBRATING 14 YEARS OF UNMATCHED EXCELLENCE!

23 - 24 March 2027 Sands Expo & Convention Centre, Singapore
Part of Biopharma APAC Confex 2027
Register Now Post-Event Report
Co-located Events
BSCA 2027 (White) Visit Brochure
CTFA 2027 (White) Visit Brochure
ADC 2027 (White) Visit Brochure
CGTWA 2027 White Logo Visit Brochure
OPWA 2027 - White Logo Visit Brochure
Awards

About the Event

The 14th Annual Biologics Manufacturing Asia 2027 is Asia’s premier bioprocessing-focused conference, providing a dedicated platform for regional biopharmaceutical industry stakeholders to network, explore strategic collaborations, and gain insights into the latest manufacturing technologies and advancements.

This year’s agenda is designed to highlight success stories from Asia’s leading biopharma companies while incorporating technical expertise from global biopharma leaders, top pharmaceutical companies, and regulators. Key topics will include cutting-edge manufacturing technologies such as single-use systems and end-to-end continuous processing, challenges and opportunities in biomanufacturing, advancements in upstream process development, cost optimization and timeline reduction in downstream processing, analytical characterization strategies, facility design and scale-up, emerging biologics manufacturing technologies, regulatory updates, and novel biologics modalities.

What we'll cover

Key Themes

Cutting-Edge Manufacturing Technologies
Explore the latest breakthroughs in single-use systems, end-to-end continuous processing, and next-generation biologics manufacturing innovations that will redefine productivity and efficiency.
Process Development & Optimization
Gain practical insights into upstream and downstream process improvements, from cost reduction to timeline acceleration, to ensure your biologics pipeline stays competitive and robust.
Regulatory & Compliance Updates
Stay ahead of changing regulations with updates from international regulators and big pharma, ensuring you meet evolving requirements and quality standards across Asian markets.
Novel Modalities & Future Opportunities
Discover new opportunities in manufacturing advanced biologics and novel modalities, and learn how to overcome current challenges to unlock the full potential of next-generation therapies.
Strategic Collaboration & Networking
Connect with Asia’s top biopharma leaders and global experts through a carefully curated networking platform designed to spark strategic partnerships and drive meaningful industry collaborations
BY THE NUMBERS

Our Impact in Asia's Biopharma

1200+
Attendees
500+
Companies
120+
Speakers

Testimonials

Hear from past attendees and industry leaders

“The conference provides a forum for latest sharing and networking among biopharma peers from different organisations. The panel discussions are particularly informative as they cover realistic, contemporaneous and first-hand sharing on opportunities and challenges facing the industry and organisations. One key highlight of the conference is the ABEA Night. This prestigious recognition highlights the outstanding contributions of individual leader advancing biopharma excellence in the Asia-Pacific region.”
Vice President & Site Quality Head, Global Quality
Takeda
Singapore flag Singapore
“It was a very valuable conference experience. I was pleased to have the opportunity to present and discuss our technology with peers in the field, which led to several new and meaningful engagements. The meeting also offered a strong scientific programme, and it was inspiring to hear high-quality work from other groups. Beyond the content itself, the conference was especially useful for building new connections and opening the door to potential future collaborations.”
CTO
Singzyme
Singapore flag Singapore
“Thank you so much for organizing such a well-run event. It was truly a pleasure to contribute, and I enjoyed the atmosphere and engagement from the audience during the event.”
Corporate Performance Specialist
Biofarma
Indonesia flag Indonesia
“Overall, we believe the event was very well organized and successful. From an exhibitor’s perspective, the arrangement of 1-to-1 meetings was particularly useful and added significant value.”
Business Development Director
Pfanstiehl
Singapore flag Singapore
"Insights from industry leaders are valuable and cannot be found easily online"
Technical Steward
BioNTech
Singapore flag Singapore
“Thanks for organizing BioSupply Chain Asia, it was a good event and I have learnt a lot.”
Head of Singapore Explore Platform
Sanofi
Singapore flag Singapore
“The team was very friendly and helpful. They were committed to scheduling 1-to-1 meetings and ensuring it went smoothly.”
BDM
SGS
Singapore flag Singapore
“Good team, clever techniques to bring people in contact. Appreciate their effort and help.”
Product & Sales Manager
DrM Group
Switzerland flag Switzerland

Sponsors & Media Partners

Special thanks to our event partners, without whom we would not be able to provide this networking, learning, and collaborating platform.

Platinum Sponsor
cytiva-logo-vector
Gold Sponsors
Becton_Dickinson_logo.svg
WuXi Biologics
Silver Sponsors
Pfanstiehl-hd
Sartorius Logo
Exhibitors
DYE logo blue 1
Duoning-Logo-EN-small-1
DrM_Logo
PharmNXT Logo_COLOUR_transparent 2K
Single Use Support
Tosoh Bioscience
Truking logo 1
Hycure
Merck
avantor-inc-logo-vector
Meissner Corporation
Aber
Ami Polymer
ORKA Pharma-navyblue transparent
Infors HT
3CON-Logo_Life_Subtitle_Aqua-Grey
Associate Sponsors
Uniqculture

AGENDA AT A GLANCE

DAY 1 | Tuesday, 23 March 2027
BMA 2027
TRACK 1
TRACK 2
Leadership Panel Discussion
Building Asia's Global Leadership in Biologics, ADCs & Novel Modalities
Morning Tea Break | Exhibition Viewing & 1-1 Networking
Upstream Processing
Robust Cell Lines & Optimized Expression Systems
Downstream Processing
Advancing Final Product Quality: Polishing, Viral Clearance & Formulation
Lunch Break | Exhibition Viewing & 1-1 Networking
Upstream Processing
Process Intensification Strategies: Perfusion, Fed-Batch & High-Density Strategies
Analytics & Characterization
Next-Generation Methods for Product Quality & Process Excellence
Afternoon Tea Break | Exhibition Viewing & 1-1 Networking
Downstream Processing
Refining Primary Recovery: Product Capture, Impurity Removal & Novel Methods
MSAT & Tech Transfer Excellence
Scale-Up, Validation & Lifecycle Management
Asia Pacific Biopharma Excellence Awards 2027 | Gala Dinner
DAY 2 | Wednesday, 24 March 2027
BMA 2027
TRACK 1
TRACK 2
CMC, Analytics & Quality
Achieving CMC Excellence, Integrated Analytics, Quality Control & Regulatory Readiness
Morning Tea Break | Exhibition Viewing & 1-1 Networking
Formulation, Development & Manufacturing
Stability, Drug Product Design & Commercialization
Smart, Agile and Digital Manufacturing
Flexible Facilities, Digital First Operations and Single Use System
Lunch Break | Exhibition Viewing & 1-1 Networking
Process Analytics & Real-Time Manufacturing
PAT, Advanced Monitoring & Real-Time Release
Facility Engineering & Infrastructure Excellence
Designing, Operating & Future-Proofing Next-Generation Biomanufacturing Facilities
Afternoon Tea Break | Exhibition Viewing & 1-1 Networking
Closing Roundtable Discussion
Bridging the Gaps: Practical Solutions for Manufacturing, Trials, Logistics & Drug Development in Asia
  1. Scaling Smarter: How Can We Drive Process Intensification Without Compromising Quality?
  2. Future-Proofing Biomanufacturing: What Does a Truly Agile, Digital-First Facility Look Like in Asia?
  3. Cracking the Code on ADC Stability: What Formulation Innovations Are Showing Real Results?
  4. From Bench to Bedside: What’s Missing in Translating Preclinical ADC Wins to Clinical Success?
  5. Strategic Licensing in the Asian ADC Market: Unlocking Growth Opportunities
  6. Navigating Investment in ADCs: Securing Funding for Innovation in Asia
  7. Building a Smart, Resilient Cold Chain: What Technologies Are Actually Reducing Risk Today?
  8. Greener Logistics: How Can APAC Balance Efficiency and Sustainability in Biopharma Supply Chains?
  9. Winning Over Patients: What Engagement Strategies Are Reshaping Clinical Trial Participation in Asia?
  10. Trial Tech & Trust: How Can We Ensure Data Integrity While Embracing AI in Clinical Research?
  11. CMC Excellence in a Complex World: What Frameworks Enable Seamless Quality, Analytics, and Compliance?
  12. Intelligent Supply Chains: How Are AI, Blockchain, and Automation Rewiring Biopharma Operations?
End of Conference
CONFERENCE AGENDA

Day 1

Tuesday, 23 March 2027

Track 1
Track 2
8:50
IMAPAC Opening Remarks
8:55
Chairman Opening Remarks
TRACK
Building Asia’s Global Leadership in Biologics, ADCs & Novel Modalities
9:00
Leadership Panel Discussion: Asia’s Biologics Ambition: From Regional Manufacturing Hub to Global Innovation Powerhouse
  • Evaluating Asia’s competitive advantage in biologics development, manufacturing, and commercialization.
  • Identifying critical investments required in talent, infrastructure, and technology to compete globally.
  • Strengthening regional collaboration between governments, industry, academia, and investors.
  • Building resilient and future-ready biologics ecosystems capable of supporting next-generation therapeutics.
PANELISTS
Teck Chung Chang
Teck Chung Chang
VP, Site Quality Head, Takeda
9:50
Accelerating Development Timelines: Innovative Technologies for Biologics, ADCs & Emerging Modalities
  • Showcasing next-generation technologies enabling faster process development and optimization.
  • Exploring advanced analytical tools for improving product characterization and quality control.
  • Examining innovations in conjugation, formulation, and delivery technologies for ADCs and novel therapeutics.
  • Discussing how technology providers and CDMOs can support rapid clinical and commercial manufacturing.
Reserved for Solution Providers
10:05
Advancing Biologics Development: Enhancing Speed, Quality and Commercial Readiness
  • Implementing platform-based approaches to accelerate biologics development timelines.
  • Improving cell line development, process development, and analytical characterization strategies.
  • Managing technology transfer and global manufacturing network expansion.
  • Balancing innovation, cost-efficiency, and regulatory compliance throughout product development.
10:30
Morning Tea Break, Exhibition Viewing & 1-1 Attendee Networking
TRACK
Upstream Processing — Robust Cell Lines & Optimized Expression Systems
TRACK
Downstream Processing — Advancing Final Product Quality: Polishing, Viral Clearance & Formulation
11:15
Engineering Next-Generation Cell Lines for High Productivity, Stability & Product Quality
  • Balancing productivity, genetic stability, and critical quality attributes (CQAs) during cell line development.
  • Leveraging CRISPR, targeted integration, and host cell engineering to create robust production cell lines.
  • Strategies to address difficult-to-express proteins, bispecific antibodies, and novel biologic modalities.
  • Accelerating clone selection and characterization while maintaining regulatory compliance and manufacturability
11:15
Doing More with Less: Reducing Buffers, Water, Resin and Waste in Downstream Processing
  • Addressing the growing buffer and water footprint of large-scale biologics purification.
  • Exploring buffer concentrates, inline conditioning and alternative chromatography approaches.
  • Extending resin lifetime while maintaining cleaning effectiveness and product quality.
  • Connecting DSP sustainability improvements with manufacturing cost and facility capacity objectives.
11:40
AI, Automation & Digital Cell Line Development: Accelerating the Path to High-Producing Clones
  • How AI and machine learning are transforming clone selection, cell line screening, and process optimization.
  • Digital platforms, automated single-cell cloning, and high-throughput technologies enabling faster development cycles.
  • Using predictive analytics to improve manufacturability, productivity, and product quality outcomes.
  • Case studies demonstrating reduced timelines and increased success rates through digitalized cell line development
Reserved for Solution Providers
11:40
Polishing Under Pressure: Removing HCPs, Aggregates and Process-Related Impurities at Higher Titres
  • Designing robust polishing strategies for increasingly concentrated and complex feed streams.
  • Tackling difficult-to-remove host cell proteins, DNA, aggregates and leachables.
  • Optimising resin selection, loading capacity and operating conditions to reduce purification cycles.
  • Applying advanced analytics to understand impurity behaviour and strengthen clearance validation
Reserved for Solution Providers
11:55
Enhancing Upstream Productivity Through Advanced Media and Feed Optimization
  • Designing chemically defined media for improved cell performance.
  • Optimizing feeding strategies to maximize yield and viability.
  • Leveraging metabolomics for media development.
  • Real-world examples of process intensification through media optimization.
11:55
Formulation at Higher Concentrations: Solving Stability, Viscosity and Aggregation Challenges
  • Developing high-concentration formulations for subcutaneous and patient-friendly delivery.
  • Managing viscosity, aggregation, particle formation and protein–protein interactions.
  • Optimising excipient selection and formulation conditions to preserve long-term stability.
  • Integrating formulation development earlier with upstream and downstream process development.
12:20
Lunch – Exhibition Viewing & 1-1 Networking
TRACK
Upstream Processing: Process Intensification Strategies: Perfusion, Fed-Batch & High- Density Strategies
TRACK
Analytics & Characterization: Next-Generation Methods for Product Quality & Process Excellence
2:05
Beyond Titre: Redefining Upstream Productivity Through High-Density Process Intensification
  • Benchmark perfusion, intensified fed-batch and conventional fed-batch across titre, volumetric productivity and facility throughput.
  • Optimise cell-specific productivity, viable cell density and culture longevity without compromising CQAs.
  • Manage oxygen transfer, CO₂ accumulation, osmolality and nutrient limitations at ultra-high cell densities.
  • Determine when higher upstream productivity translates into lower COGS and smaller manufacturing footprints.
2:05
Multi-Attribute Methods 2.0: Moving MAM from Characterization into Routine QC and Product Release
  • Expanding LC-MS-based MAM from development laboratories toward QC environments for simultaneous monitoring of multiple product quality attributes.
  • Tackling method robustness, validation, data processing and comparability challenges associated with routine MAM implementation.
  • Evaluating how MAM can complement or replace conventional analytical assays without increasing regulatory risk.
  • Building regulatory confidence and harmonised implementation strategies across differing APAC market requirements.
2:30
Intensified Fed-Batch 2.0: Pushing Cell Density Without Pushing Process Risk
  • Design high-density seed trains and N-1 perfusion strategies to shorten production bioreactor occupancy.
  • Optimise inoculation density, feeding profiles and metabolic control for accelerated production cycles.
  • Prevent lactate, ammonia and other inhibitory metabolite accumulation at elevated biomass levels.
  • Evaluate the productivity-versus-complexity trade-off compared with full perfusion.
Reserved for Solution Provider
2:30
AI-Enabled Analytical Development: From Data-Rich Experiments to Faster Quality Decisions
  • Applying AI/ML to analytical method development, optimization, and interpretation of complex datasets.
  • Connecting PAT, process, and laboratory data to identify emerging quality trends.
  • Using predictive analytics to anticipate deviations, OOS/OOT results, and process drift.
  • Addressing model validation, data integrity, explainability, and regulatory acceptance across APAC
Reserved for Solution Provider
2:45
Intensification Without Compromise: Controlling CQAs in High-Density and Continuous Cultures
  • Understand how prolonged culture duration and altered cellular metabolism influence glycosylation, charge variants and aggregation.
  • Define CPP–CQA relationships specifically for perfusion and high-density processes.
  • Establish comparability strategies when transitioning commercial molecules from conventional fed-batch to intensified platforms.
  • Build control strategies that satisfy evolving expectations for continuous and intensified biomanufacturing in APAC.
2:45
Next-Generation Impurity Analytics: Detecting the Unknowns Before They Become a Quality Risk
  • Advancing detection and quantification of host-cell proteins, residual DNA, aggregates, fragments, process-related impurities and product variants.
  • Applying high-resolution MS, NGS and orthogonal analytical technologies to detect low-abundance and previously unidentified impurities.
  • Connecting impurity profiles with upstream and downstream process parameters to improve root-cause analysis and clearance strategies.
  • Developing risk-based impurity control strategies that remain robust through process changes, scale-up and technology transfer.
3:10
Breaking the Density Barrier: Engineering Robust High-Cell-Density Cultures at Commercial Scale
  • Optimising cell-line performance, media composition, feeding strategies, and process parameters at ultra-high cell densities.
  • Addressing oxygen transfer, CO₂ accumulation, osmolality, metabolite build-up, and mixing limitations as density increases.
  • Understanding how intensified culture conditions influence CQAs, glycosylation, aggregation, and product consistency.
  • Translating high-density performance from development-scale bioreactors into reliable GMP manufacturing.
Reserved for Solution Provider
3:10
Beyond Manual Testing: Accelerating Quality Decisions Through Automated Analytics
  • Advancing automated sample preparation, testing and data analysis to improve throughput, reproducibility and right-first-time results.
  • Integrating robotics, miniaturised assays and high-throughput analytical platforms to accelerate testing across development and commercial manufacturing.
  • Connecting laboratory automation with LIMS, ELN and manufacturing systems to enable seamless data flow and faster quality decisions.
  • Overcoming APAC implementation barriers around validation, legacy-system integration, workforce readiness and investment justification.
Reserved for Solution Provider
3:25
Afternoon Tea Break, Exhibition Viewing & 1-1 Attendee Networking
TRACK
Downstream Processing — Refining Primary Recovery: Product Capture, Impurity Removal & Novel Methods
TRACK
MSAT & Tech Transfer Excellence: Scale-Up, Validation & Lifecycle Management
4:10
Capture Chromatography Under Pressure: Extending Resin Lifetime Without Compromising Product Quality
  • Optimising Protein A loading, cycling and resin utilisation as titres continue to increase.
  • Controlling resin fouling, ligand leaching and performance deterioration over extended campaigns.
  • Evaluating high-capacity resins, membranes and alternative affinity technologies to reduce capture bottlenecks.
  • Building resin lifecycle and cleaning strategies suited to APAC's growing multi-product manufacturing environment.
4:10
Raw Materials Under Control: Managing Variability During Scale-Up, Transfer & Commercial Manufacturing
  • Identifying raw-material attributes with the greatest impact on process performance and product quality
  • Managing supplier, lot-to-lot and regional sourcing variability during site transfers
  • Developing material qualification and risk-ranking strategies based on process understanding
  • Using MSAT and manufacturing data to establish relationships between material variability and CQAs
4:35
Smarter Impurity Clearance: Tackling HCP, DNA, Aggregates & Process-Related Contaminants
  • Understanding how intensified upstream processes change host-cell protein and impurity profiles.
  • Improving removal of HCP, residual DNA, aggregates, leachables and other process-related impurities.
  • Applying orthogonal purification strategies to address difficult-to-remove contaminants.
  • Using enhanced analytics to understand impurity trajectories and optimise downstream unit operations.
Reserved for Solution Provider
4:35
From Development to Commercial Scale: De-Risking Biologics Scale-Up Without Losing Process Performance
  • Translating small-scale process understanding into robust commercial-scale operating ranges
  • Managing scale-dependent CPPs, mass transfer, mixing, shear and bioreactor geometry
  • Using engineering runs, scale-down models and risk assessments to predict scale-up failure
  • Building MSAT strategies that shorten the path from clinical manufacturing to PPQ
4:50
Continuous & Intensified Downstream Processing: Moving from Unit Operations to Integrated Purification
  • Integrating continuous chromatography, filtration and buffer management into connected downstream workflows.
  • Overcoming process-control and equipment-integration challenges associated with continuous manufacturing.
  • Using PAT and real-time monitoring to maintain critical quality attributes during intensified processing.
  • Determining where continuous downstream processing delivers meaningful productivity and COGS advantages in APAC.
4:50
Managing Change Without Revalidating Everything: Smarter Lifecycle & Post-Approval Change Management
  • Applying science- and risk-based approaches to determine the validation impact of process changes
  • Leveraging established conditions and Post-Approval Change Management Protocols
  • Managing equipment, raw-material, scale and site changes without compromising the validated state
  • Navigating different APAC expectations for variations and post-approval CMC changes
5:15
Driving Down Cost of Goods: Maximising Downstream Productivity, Efficiency & Facility Utilisation
  • Optimising resin utilisation, buffer consumption and water demand while maintaining yield, purity and critical quality attributes.
  • Leveraging buffer concentrates, inline conditioning and inline dilution to reduce preparation burden, storage requirements and facility complexity.
  • Applying downstream process intensification to increase throughput and capacity within brownfield and space-constrained APAC manufacturing facilities.
  • Translating DSP improvements into measurable gains in cost per batch, cost per gram, facility utilisation and manufacturing capacity.
5:15
Tech Transfer Under Pressure: Achieving Right-First-Time Transfer Across APAC Manufacturing Networks
  • Identifying hidden gaps between sending-unit process knowledge and receiving-site capabilities
  • Assessing equipment, facility, raw-material and analytical differences before transfer execution
  • Establishing clear MSAT, process development, quality, engineering and manufacturing ownership
  • Developing readiness metrics and stage-gate models to reduce deviations and repeat engineering runs
5:40
Chairman’s Closing Remarks
5:45
End of day 1
6:00
Cocktails & Networking
6:30
Asia Pacific Biopharma Excellence Awards 2027 | Gala Dinner
CONFERENCE AGENDA

Day 2

Wednesday, 24 March 2027

Track 1
Track 2
8:50
IMAPAC Opening Remarks
8:55
Chairman Opening Remarks
TRACK
CMC, Analytics & Quality Achieving CMC Excellence, Integrated Analytics, Quality Control & Regulatory Readiness (Combined Track 1 and Track 2)
9:00
Regulatory-Ready CMC: Designing Global Development Programs for FDA, EMA & APAC Expectations
  • Building CMC strategies that anticipate evolving requirements across FDA, EMA and key APAC regulators.
  • Aligning analytical validation, process validation, comparability and stability strategies for global submissions.
  • Managing post-approval changes, manufacturing changes and lifecycle comparability without disrupting supply.
  • Strengthening regulatory engagement and documentation to reduce CMC questions, review cycles and approval delays.
9:50
Platform Analytics: Leveraging Analytical Methods Across Products and Development Pipelines
  • Establishing platform analytical procedures that can be applied across related molecules, modalities, and product families while maintaining product-specific scientific rigor.
  • Streamlining method development, qualification, and validation by leveraging prior analytical knowledge and proven platform capabilities.
  • Designing robust bridging and method-transfer strategies across products, manufacturing sites, QC laboratories, and global testing networks.
  • Defining the scientific evidence, comparability data, and regulatory justification required to support the use of platform methods across multiple products.
Reserved for Solution Providers
10:05
Comparability Under Pressure: Managing CMC Change Across Scale-Up, Tech Transfer & Manufacturing Networks
  • Designing comparability strategies for process changes, scale-up, site transfers, and manufacturing expansion.
  • Determining when analytical comparability is sufficient and when additional non-clinical or clinical evidence may be required.
  • Using orthogonal and advanced characterization methods to demonstrate product consistency.
  • Building change management strategies that enable manufacturing flexibility without creating regulatory delays.
10:30
Morning Tea Break, Exhibition Viewing & 1-1 Attendee Networking
TRACK
Formulation, Development & Manufacturing: — Stability, Drug Product Design & Commercialization
TRACK
Smart, Agile and Digital Manufacturing — Flexible Facilities, Digital First Operations and Single Use System
11:15
From Molecule to Medicine: Designing Drug Products for Stability, Delivery & Manufacturability
  • Translating molecule characteristics into the right formulation and dosage-form strategy.
  • Balancing potency, concentration, viscosity, stability, and patient usability.
  • Applying QbD to identify critical quality attributes and formulation design space.
  • Avoiding late-stage redesign by integrating manufacturing requirements from the outset.
11:15
From Fixed to Flexible: Designing Multi-Product Facilities for Asia’s Changing Biologics Pipeline
  • Designing facilities that can rapidly switch between products, modalities, and batch sizes.
  • Balancing ballroom, modular, and traditional facility configurations for different manufacturing needs.
  • Minimising changeover time, cross-contamination risk, and production downtime in multi-product environments.
  • Building flexibility into utilities, equipment, automation, and process flows without overengineering capacity.
11:40
Freeze, Dry or Reformulate? Advancing Lyophilization & Alternative Stability Strategies
  • Determining when lyophilization offers advantages over liquid formulations.
  • Optimizing freezing, primary drying, secondary drying, and cycle development.
  • Applying modeling and PAT to improve lyophilization robustness and cycle efficiency.
  • Scaling lyophilization processes while maintaining critical quality attributes and product stability.
Reserved for Solution Providers
11:40
Single-Use at Scale: Solving Cost, Supply and Sustainability Constraints
  • Where single-use technologies deliver the strongest operational and economic advantages versus stainless steel.
  • Addressing extractables/leachables, integrity, standardisation, and supplier qualification challenges.
  • Reducing dependence on imported consumables through stronger regional supply networks and dual sourcing.
  • Tackling plastic waste and developing credible sustainability strategies for disposable manufacturing systems.
11:55
Formulation Under Pressure: Solving Stability Challenges Before They Derail Development
  • Identifying degradation pathways and critical stability risks earlier in development.
  • Tackling aggregation, oxidation, deamidation, hydrolysis, and other product-specific liabilities.
  • Using predictive stability models and accelerated studies to guide formulation decisions.
  • Building stability-indicating strategies that support longer shelf life and commercialization.
11:55
Plug, Play, Scale: Modular Manufacturing for Faster Capacity Deployment
  • Using modular and prefabricated manufacturing concepts to shorten facility design, construction, and qualification timelines.
  • Creating repeatable manufacturing modules that can be replicated across Asian markets.
  • Matching modular capacity with uncertain demand and increasingly diversified biologics pipelines.
  • Managing regulatory, validation, utility, and technology-transfer challenges when scaling modular facilities.
12:20
Lunch – Exhibition Viewing & 1-1 Networking
TRACK
Process Analytics & Real-Time Manufacturing: — PAT, Advanced Monitoring & Real-Time Release
TRACK
Facility Engineering & Infrastructure Excellence: Designing, Operating & Future-Proofing Next-Generation Biomanufacturing Facilities
2:05
From PAT to RTRT: Building the Roadmap to Real-Time Release in Biologics
  • Translating PAT data into defensible real-time release strategies for biologics.
  • Connecting CPPs, CQAs and in-process measurements to release decisions.
  • Validating PAT models and demonstrating continued model performance.
  • Regulatory and operational barriers to moving from conventional QC release to RTRT.
2:05
From Design to GMP Operations: De-Risking Commissioning, Qualification & Facility Start-Up
  • Integrating C&Q requirements from concept and detailed design stages
  • Risk-based commissioning and qualification of facilities and utilities
  • Improving handover between engineering, validation, quality and operations
  • Avoiding common start-up failures that delay GMP readiness and production
2:30
Soft Sensors & Virtual Measurements: Predicting What You Cannot Measure In-Line
  • Developing soft sensors for CQAs that cannot be directly measured continuously.
  • Combining process data, mechanistic models and multivariate analytics.
  • Model calibration, validation and lifecycle management across batches and sites.
  • Using predictive signals for earlier deviation detection and proactive intervention.
Reserved for Solution Providers
2:30
Engineering the Cleanroom of the Future: Smarter HVAC, Zoning & Energy Optimization
  • Optimizing air-change rates without compromising GMP requirements
  • Risk-based cleanroom classification and HVAC zoning
  • Applying CFD and dynamic environmental control to facility design
  • Reducing HVAC energy consumption and lifecycle operating costs
2:45
PAT Across the Bioprocess: Connecting Upstream, Downstream & Product Quality
  • Deploying PAT from cell culture and harvest through chromatography and formulation
  • Monitoring CQAs and CPPs across interconnected unit operations
  • Connecting upstream variability with downstream purification performance
  • Building an integrated analytical control strategy instead of isolated PAT applications
2:45
Contamination Control by Design: Engineering Facilities for Annex 1 & PIC/S Readiness
  • Embedding contamination control strategy into facility layout and engineering design
  • Engineering pressure cascades, segregation and personnel/material flows
  • Integrating barrier technologies, environmental monitoring and closed processing
  • Designing facilities that maintain inspection readiness throughout their operational lifecycle
3:10
Digital Twins for Biologics: From Process Simulation to Real-Time Control
  • Developing hybrid digital twins using first-principles models and manufacturing data
  • Connecting PAT measurements to continuously update process-state estimates
  • Predicting deviations, yield and product-quality outcomes before they occur
  • Using digital twins for scale-up, process optimization, operator decision support and control
3:10
Capacity Without Overbuilding: Engineering the Right Facility for Asia's Next Biologics Pipeline
  • Using dynamic capacity modelling to determine facility size and configuration
  • Balancing current demand against uncertain future pipeline requirements
  • Deciding when to expand, retrofit, modularize or build greenfield capacity
  • Avoiding over-engineering while retaining sufficient flexibility for future products and technologies
3:35
Afternoon Tea Break, Exhibition Viewing & 1-1 Attendee Networking
TRACK
Closing Roundtable Discussion: Bridging the Gaps: Practical Solutions for Manufacturing, Trials, Logistics & Drug Development in Asia
4:20
Scaling Smarter: How Can We Drive Process Intensification Without Compromising Quality?
  • Future-Proofing Biomanufacturing: What Does a Truly Agile, Digital-First Facility Look Like in Asia?
  • Cracking the Code on ADC Stability: What Formulation Innovations Are Showing Real Results?
  • From Bench to Bedside: What’s Missing in Translating Preclinical ADC Wins to Clinical Success?
  • Strategic Licensing in the Asian ADC Market: Unlocking Growth Opportunities
  • Navigating Investment in ADCs: Securing Funding for Innovation in Asia
  • Building a Smart, Resilient Cold Chain: What Technologies Are Actually Reducing Risk Today?
  • Greener Logistics: How Can APAC Balance Efficiency and Sustainability in Biopharma Supply Chains?
  • Winning Over Patients: What Engagement Strategies Are Reshaping Clinical Trial Participation in Asia?
  • Trial Tech & Trust: How Can We Ensure Data Integrity While Embracing AI in Clinical Research?
  • CMC Excellence in a Complex World: What Frameworks Enable Seamless Quality, Analytics, and Compliance?
  • Intelligent Supply Chains: How Are AI, Blockchain, and Automation Rewiring Biopharma Operations?
5:20
Chairman’s Closing Remarks
5:30
End of day 2

Awards & Recognition

Asia-Pacific Biopharma Excellence Awards 2027
23rd March 2027 | Sands Expo & Convention Centre, Singapore
The Asia-Pacific Biopharma Excellence Awards (ABEA) 2027 aims to honour exceptional achievements in the Asian biopharma sector, recognizing excellence in bioprocessing, logistics and supply chain management, antibody-drug conjugates (ADC), and clinical trials over the past year. Celebrating the remarkable contributions of leading biopharma professionals, organizations, and technologies, the awards spotlight trailblazing leaders and trendsetters shaping the industry's future while inspiring innovation for tomorrow’s biopharma landscape.
Learn More About Our Awards
By Profile
Asian Biopharma
45%
International Biopharma
20%
CMOs
15%
Academic & Research Institutes
10%
Technology & Service Providers
10%
By Job Title
VPs & Directors of Process Development
25%
USP & DSP Specialists & Researchers
25%
Head of Quality Assurance & Analytics
20%
Head of Manufacturing & Bioprocessing
15%
Business Development & Marketing
15%
By Geography
World Map
25%
Korea & Japan
18%
China, Taiwan & Hong Kong
25%
Singapore
20%
Indonesia, Australia, Thailand, India & Malaysia
12%
USA & Europe
25%
Korea & Japan
18%
China, Taiwan & Hong Kong
25%
Singapore
20%
Indonesia, Australia, Thailand, India & Malaysia
12%
USA & Europe

Who Should Sponsor?

BIOMANUFACTURING SOFTWARE
CELL CULTURE AND FERMENTATION
PROCESS OPTIMIZATION
CRYOPRESERVATION
HIGH-THROUGHPUT SCREENING
MICROFLUIDICS
BIOSENSOR TECHNOLOGY
GENE THERAPY TECHNOLOGY
SINGLE-USE TOOLS
DRUG DELIVERY
BIOPROCESSING EQUIPMENT
CELL LINE DEVELOPMENT
NEXT-GENERATION SEQUENCING
BIOINFORMATICS
BIOSENSOR TECHNOLOGY
AUTOMATION AND ROBOTICS
3D BIOPRINTING
GENE EDITING
CONTINUOUS MANUFACTURING
SPONSORSHIP BENEFITS

Why Sponsor This Event?

Thought Leadership

Present Your Expertise to the Biopharma Industry's Key Stakeholders through a Variety of Available Speaking Packages.

Host a Panel Discussion

Moderate a panel discussion including one representative from your company with 3 representatives from the end user side to share views on a current industry topic

Duration: 45 minutes

Showcase Your Solutions to Educate the Market

Join in for dedicated CMO & CRO Showcases for German Market

Branding

Emphasize on your Message by Marketing and Promoting Alongside the Event

Networking & Lead Generation

Gain Exclusive Access to Contacts of High Profile Attendees through Intimate Networking Opportunities

Our Past Partners

Sartorius Logo
Becton_Dickinson_logo.svg
IDBS_Logo
WuXi Biologics
Merck
solventum-logo-horz-clr-pos-rgb
Pfanstiehl-hd
DYE logo blue 1
Aurigene
lonza
cytiva-logo-vector
avantor-inc-logo-vector
Charles_River_Laboratories_Logo.svg
Truking logo 1
cellist-1
watson-marlow (1)
Aber
Single Use Support
PharmNXT Logo_COLOUR_transparent 2K
Tosoh Bioscience
Emerson_Electric_Company
Dr Paul Lohman
avantor-inc-logo-vector
Genscript GS_Logo_Primary_RGB
Acro Biosystems
Shimadzu 1
Tofflon
Jiuzhou
IKA_Logo
Gerresheimer 2
Imalife
Lisure Science
Ellab_Logo_tagline_CYAN 2_page-0001
airdynamics
unither-pharma
ATUM_RGB_Black 1
Sanisure
SHENTEK logo
Duoning-Logo-EN-small-1
Evonik
Biomed Logo (Dark Blue & Light Blue) (1) (1)
novo-nordisk
SGS_Logo.svg
Sphere Bio-use this Dark Green WSTB Primary@300x-8 1
Biohaus Media (Media Partner) Logo
BioPharma Asia Logo
Agilent-Logo-Site
Refeyn-01
and many more...
PARTNER WITH US

Sponsorship Packages

Tailored sponsorship opportunities designed to maximize your brand visibility and lead generation.

Platinum Sponsor
Enquire Platinum

Branding

  • 1 Priority positioning of corporate logo as "Platinum Sponsor" on the front page of the Official Conference Brochure distributed to more than 20,000 carefully targeted senior executives
  • 1 Priority positioning of corporate logo as "Platinum Sponsor" on event web page with hyperlink to and from your website.
  • 1 Corporate profile (max 200 words) to appear within the Official event webpage
  • 1 Priority positioning of corporate logo as "Platinum Sponsor" on each event ad placed in the event's media partner's publications and on Imapac's marketing campaign including social Media activity.
  • 1 Brochure Distribution at the Registration Desk/Conference Table
  • 1 Distribution of corporate gifts (optional)

Onsite Benefits

  • 1 Pre-Conference Workshop (Half day) including room rental and 1 refreshment for 30 pax (limited to 1-2 Sponsors)
  • 1 20 mins presentation with 5 mins live Q&A to be presented during the main conference session
  • 1 Complimentary 20 mins end-user client case study presentation with 5 mins live Q&A to be presented during the main conference session
  • 1 Chairmanship on Conference Day 2 (optional and subject to availability)
  • 1 12sqm (6mx2m) Table Top Exhibition at Exhibition Hall (complimentary upgrade to 18sqm)
  • 1 Speaker Pass to attend the premium conference sessions and network at the Exhibition Hall
  • 7 Conference Pass to attend the premium conference sessions and network at the Exhibition Hall
  • 2 Exhibitor Pass to man the booth in the Exhibition Hall
  • 1 In-depth post-event report exclusively available to sponsors

Engagement Benefits

  • 1 Pre-event Speaker Interview to be shared with Biologics community & social media activities
  • 5 Assistance in setting up 1:1 meeting with targeted companies onsite
Gold Sponsor
Enquire Gold

Branding

  • 1 Priority positioning of corporate logo as "Gold Sponsor" on the front page of the Official Conference Brochure distributed to more than 20,000 carefully targeted senior executives
  • 1 Priority positioning of corporate logo as "Gold Sponsor" on event web page with hyperlink to and from your website.
  • 1 Corporate profile (max 150 words) to appear within the Official event webpage
  • 1 Priority positioning of corporate logo as "Gold Sponsor" on each event ad placed in the event's media partner's publications and on Imapac's marketing campaign including social Media activity.
  • 1 Priority positioning of corporate logo as "Gold Sponsor" on conference backdrop, on-site signage, event banners and etc
  • 1 Brochure Distribution at the Registration Desk/Conference Table
  • 1 Distribution of corporate gifts (optional)

Onsite Benefits

  • 1 20 mins presentation with 5 mins live Q&A to be presented during the main conference session
  • 1 Complimentary Moderator role at panel / roundtable
  • 1 9sqm (4.5x2m) Table Top Exhibition at Exhibition Hall (complimentary upgrade to 12sqm)
  • 1 Speaker Pass to attend the premium conference sessions and network at the Exhibition Hall
  • 6 Conference Pass to attend the premium conference sessions and network at the Exhibition Hall
  • 2 Exhibitor Pass to man the booth in the Exhibition Hall
  • 1 In-depth post-event report exclusively available to sponsors

Engagement Benefits

  • 1 Pre-event Speaker Interview to be shared with Biologics community & social media activities
  • 5 Assistance in setting up 1:1 meeting with targeted companies onsite
Silver Sponsor (Enhanced)
Enquire Silver Enhanced

Branding

  • 1 Positioning of corporate logo as "Silver Sponsor" on the front page of the Official Conference Brochure distributed to more than 20,000 carefully targeted senior executives
  • 1 Positioning of corporate logo as "Silver Sponsor" on event web page with hyperlink to and from your website.
  • 1 Corporate profile (max 100 words) to appear within the Official event webpage
  • 1 Positioning of corporate logo as "Silver Sponsor" on each event ad placed in the event's media partner's publications and on Imapac's marketing campaign including social Media activity.
  • 1 Positioning of corporate logo as "Silver Sponsor" on conference backdrop, on-site signage, event banners and etc

Onsite Benefits

  • 1 25 mins presentation with live Q&A to be presented during the main conference session
  • 1 6sqm (3x2m) Table Top Exhibition at Exhibition Hall (complimentary upgrade to 9sqm booth)
  • 1 Speaker Pass to attend the premium conference sessions and network at the Exhibition Hall
  • 4 Conference Pass to attend the premium conference sessions and network at the Exhibition Hall
  • 2 Exhibitor Pass to man the booth in the Exhibition Hall
  • 1 In-depth post-event report exclusively available to sponsors
Silver Sponsor
Enquire Silver

Branding

  • 1 Positioning of corporate logo as "Silver Sponsor" on the front page of the Official Conference Brochure distributed to more than 20,000 carefully targeted senior executives
  • 1 Positioning of corporate logo as "Silver Sponsor" on event web page with hyperlink to and from your website.
  • 1 Corporate profile (max 100 words) to appear within the Official event webpage
  • 1 Positioning of corporate logo as "Silver Sponsor" on each event ad placed in the event's media partner's publications and on Imapac's marketing campaign including social Media activity.
  • 1 Positioning of corporate logo as "Silver Sponsor" on conference backdrop, on-site signage, event banners and etc

Onsite Benefits

  • 1 15 mins presentation with live Q&A to be presented during the main conference session
  • 1 6sqm (3x2m) Table Top Exhibition at Exhibition Hall
  • 1 Speaker Pass to attend the premium conference sessions and network at the Exhibition Hall
  • 3 Conference Pass to attend the premium conference sessions and network at the Exhibition Hall
  • 2 Exhibitor Pass to man the booth in the Exhibition Hall
  • 1 In-depth post-event report exclusively available to sponsors
Bronze Sponsor
Enquire Bronze

Branding

  • 1 Positioning of corporate logo as "Bronze Sponsor" on the front page of the Official Conference Brochure distributed to more than 20,000 carefully targeted senior executives
  • 1 Positioning of corporate logo as "Bronze Sponsor" on event web page with hyperlink to and from your website.
  • 1 Corporate profile (max 100 words) to appear within the Official event webpage
  • 1 Positioning of corporate logo as "Bronze Sponsor" on each event ad placed in the event's media partner's publications and on Imapac's marketing campaign including social Media activity.
  • 1 Positioning of corporate logo as "Bronze Sponsor" on conference backdrop, on-site signage, event banners and etc

Onsite Benefits

  • 1 15 mins presentation with live Q&A to be presented during the main conference session
  • 1 Complimentary 1sqm space for banner display and/or small networking table at Exhibition Hall (Complimentary upgrade to 6sqm (3x2m) Table Top at Exhibition Hall for First Time Clients ONLY - one time offer)
  • 1 Speaker Pass to attend the premium conference sessions and network at the Exhibition Hall
  • 1 Conference Pass to attend the premium conference sessions and network at the Exhibition Hall
  • 1 In-depth post-event report exclusively available to sponsors
Exhibitor
Enquire Exhibitor

Branding

  • 1 Positioning of corporate logo as "Exhibitor" on the front page of the Official Conference Brochure distributed to more than 20,000 carefully targeted senior executives
  • 1 Positioning of corporate logo as "Exhibitor" on event web page with hyperlink to and from your website.
  • 1 Corporate profile (max 100 words) to appear within the Official event webpage
  • 1 Positioning of corporate logo as "Exhibitor" on each event ad placed in the event's media partner's publications and on Imapac's marketing campaign including social Media activity.
  • 1 Positioning of corporate logo as "Exhibitor" on conference backdrop, on-site signage, event banners and etc

Onsite Benefits

  • 1 1-2 mins promotional video to be played during the 2 days event ad slots
  • 1 6sqm (3x2m) Table Top Exhibition at Exhibition Hall
  • 2 Conference Pass to attend the premium conference sessions and network at the Exhibition Hall
  • 2 Exhibitor Pass to man the booth in the Exhibition Hall
  • 1 In-depth post-event report exclusively available to sponsors

Be a Part of This Event!

Don't miss out on unique networking, speaking and sponsorship opportunities.

Register Here! Post-Event Report
Head of Production
Lara Santiago
+63 9176 210686
Senior Conference Producer
Melina Dass
+65 6230 3594
Business Development Manager
Ana Laxamana
+65 6983 6132
Business Development Manager
Nathan Grace Niño
+65 6983 6134